SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-16-455603
Filing Date
2016-02-10
Accepted
2016-02-09 18:21:54
Documents
2
Group Members
ANSBERT GADICKEJAMES PAUL SCOPALUKE EVNINMPM ASSET MANAGEMENT INVESTORS BV4 LLCMPM ASSET MANAGEMENT INVESTORS BV5 LLCMPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KGMPM BIOVENTURES IV GP LLCMPM BIOVENTURES IV LLCMPM BIOVENTURES V GP LLCMPM BIOVENTURES V LLCM

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d133161dsc13ga.htm SC 13G/A 232794
2 EX-99.A d133161dex99a.htm EX-99.A 21677
  Complete submission text file 0001193125-16-455603.txt   256617
Mailing Address 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116 617-425-9200
MPM BioVentures IV QP LP (Filed by) CIK: 0001358309 (see all company filings)

IRS No.: 204217788 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Subject) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87858 | Film No.: 161401487
SIC: 2834 Pharmaceutical Preparations